A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea

Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis

NCT06311123 ·Status: RECRUITING

To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

NCT03915769 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)

NCT05644665 ·Status: TERMINATED ·Phase: PHASE3

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

NCT05076175 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis

NCT07271069 ·Status: RECRUITING

Efficacy and Safety Study of Ozanimod in Ulcerative Colitis

NCT01647516 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their Infants

NCT06126835 ·Status: ACTIVE_NOT_RECRUITING

Define Predictors of Response to Ozanimod in UC Discovering Biomarkers in the Management of Ulcerative Colitis

NCT05809583 ·Status: WITHDRAWN

Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis

NCT06290934 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phase II Study of HMPL-004 in Patients With Ulcerative Colitis

NCT00659802 ·Status: COMPLETED ·Phase: PHASE2

Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis

NCT04607837 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis

NCT00808977 ·Status: COMPLETED ·Phase: PHASE2

Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients

NCT04071405 ·Status: COMPLETED

A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis

NCT05549323 ·Status: TERMINATED ·Phase: PHASE1

BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis

NCT03648541 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis

NCT03893565 ·Status: TERMINATED ·Phase: PHASE2

Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

NCT02958865 ·Status: COMPLETED ·Phase: PHASE2

Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis

NCT06029972 ·Status: RECRUITING ·Phase: PHASE2

A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis

NCT01959282 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis

NCT02895100 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis

NCT04096573 ·Status: WITHDRAWN ·Phase: PHASE2

Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis

NCT01612039 ·Status: COMPLETED ·Phase: PHASE2

Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis

NCT04882007 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Adult Patients with Active Mild to Moderate Ulcerative Colitis

NCT06725017 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy

NCT05470985 ·Status: TERMINATED ·Phase: PHASE2/PHASE3